Free Trial

Benitec Biopharma (BNTC) Institutional Ownership

Benitec Biopharma logo
$11.30 -0.27 (-2.33%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$11.01 -0.29 (-2.60%)
As of 02/21/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)

Current
Institutional Ownership
Percentage
52.19%
Number of
Institutional Buyers
(last 12 months)
14
Total
Institutional Inflows
(last 12 months)
$141.46M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$7.49M
Get BNTC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BNTC Institutional Buying and Selling by Quarter

Benitec Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2025 AWM Investment Company Inc.102,027$1.29M0.2%-83.7%0.439%
2/17/2025 Suvretta Capital Management LLC8,960,009$113.17M3.9%+1.5%38.587%
2/17/2025 Lion Point Capital LP62,000$783K4.1%+59.0%0.267%
2/17/2025 Janus Henderson Group PLC2,616,427$33.27M0.0%+198.5%11.268%
2/17/2025 Ameriprise Financial Inc.35,476$448K0.0%+138.4%0.153%
2/17/2025 683 Capital Management LLC35,817$452K0.0%N/A0.154%
2/14/2025 Schonfeld Strategic Advisors LLC260,417$3.29M0.0%-4.5%1.122%
2/14/2025 Northern Trust Corp38,200$482K0.0%+54.2%0.165%
2/14/2025 Adage Capital Partners GP L.L.C.1,972,524$24.91M0.0%+134.4%8.495%
2/14/2025 MYDA Advisors LLC50,000$632K0.2%N/A0.215%
2/12/2025 Geode Capital Management LLC197,096$2.49M0.0%+134.7%0.849%
2/12/2025 Franklin Resources Inc.2,939,287$37.12M0.0%+269.0%12.658%
2/11/2025 Simplify Asset Management Inc.76,337$964K0.0%-34.5%0.329%
11/16/2024 Geode Capital Management LLC83,987$772K0.0%+31.3%0.795%
11/15/2024 Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300%
11/14/2024 Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640%
11/14/2024 Acuta Capital Partners LLC29,800$274K0.2%N/A0.282%
11/6/2024 Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104%
10/7/2024 GAMMA Investing LLC6,540$60K0.0%+20.3%0.070%
8/20/2024 Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982%
8/13/2024 Simplify Asset Management Inc.51,216$358K0.0%N/A0.547%
7/2/2024 GAMMA Investing LLC5,438$38K0.0%+53.0%0.058%
5/16/2024 Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440%
11/15/2023 Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419%
11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848%
11/15/2022 Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478%
11/14/2022 Armistice Capital LLC1,555,039$578K0.0%N/A6.025%
11/14/2022 Altium Capital Management LP658,796$245K0.1%N/A2.552%
11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244%
8/16/2021 State Street Corp21,000$89K0.0%N/A0.267%
8/13/2021 Renaissance Technologies LLC42,700$181K0.0%N/A0.544%
8/13/2021 Northern Trust Corp11,813$50K0.0%N/A0.150%
8/13/2021 Geode Capital Management LLC34,493$146K0.0%+20.8%0.439%
8/13/2021 Vanguard Group Inc.74,773$318K0.0%+43.3%0.952%
8/11/2021 Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190%
7/31/2021 Private Wealth Advisors LLC15,043$64K0.0%N/A0.192%
5/21/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483%
5/19/2021 Virtu Financial LLC22,520$116K0.0%+17.8%0.467%
5/18/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483%
5/13/2021 Bank of New York Mellon Corp17,653$91K0.0%N/A0.366%
The FED is losing the war on inflation (Ad)

It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…

You can go here to give yourself a head start.
5/12/2021 Geode Capital Management LLC28,560$147K0.0%N/A0.593%
4/14/2021 WealthTrust Axiom LLC12,950$66K0.0%N/A0.269%
4/12/2021 HighPoint Advisor Group LLC93,000$462K0.1%N/A1.930%
3/4/2021 Hudson Bay Capital Management LP107,995$324K0.0%N/A2.241%
2/24/2021 Virtu Financial LLC19,114$57K0.0%N/A0.397%
2/16/2021 Warberg Asset Management LLC10,000$30K0.0%N/A0.903%
2/10/2021 Renaissance Technologies LLC50,660$152K0.0%N/A4.572%
(Data available from 1/1/2016 forward)

BNTC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BNTC shares?

During the previous two years, 16 institutional investors and hedge funds held shares of Benitec Biopharma. The most heavily invested institutionals were Suvretta Capital Management LLC ($113.17M), Franklin Resources Inc. ($37.12M), Janus Henderson Group PLC ($33.27M), Adage Capital Partners GP L.L.C. ($24.91M), Nantahala Capital Management LLC ($5.88M), Schonfeld Strategic Advisors LLC ($3.29M), and Geode Capital Management LLC ($2.49M).Learn more on BNTC's institutional investors.

What percentage of Benitec Biopharma stock is owned by institutional investors?

52.19% of Benitec Biopharma stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings.

Which institutional investors have been buying Benitec Biopharma stock?

Of the 14 institutional investors that purchased Benitec Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($7.27M), Franklin Resources Inc. ($2.14M), Janus Henderson Group PLC ($1.80M), Adage Capital Partners GP L.L.C. ($1.32M), Nantahala Capital Management LLC ($841.40K), Geode Capital Management LLC ($133.12K), and Simplify Asset Management Inc. ($116.54K).

How much institutional buying is happening at Benitec Biopharma?

Institutional investors have bought a total of 13,802,351 shares in the last 24 months. This purchase volume represents approximately $142.03M in transactions.

Which Benitec Biopharma major shareholders have been selling company stock?

The following institutional investors have sold Benitec Biopharma stock in the last 24 months: AWM Investment Company Inc. ($522.97K), Simplify Asset Management Inc. ($40.20K), Janus Henderson Group PLC ($24.29K), and Schonfeld Strategic Advisors LLC ($12.40K).

How much institutional selling is happening at Benitec Biopharma?

Institutional investors have sold a total of 599,864 shares in the last 24 months. This volume of shares sold represents approximately $7.49M in transactions.



This page (NASDAQ:BNTC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners